Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor suppressor p53 is required to modulate BRCA1 expression.

P Arizti1, L Fang, I Park

  • 1Department of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, Massachusetts 02115, USA.

Molecular and Cellular Biology
|September 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal hyperparathyroidism: comparative outcomes of parathyroidectomy in two regional centres over 14 years.

Annals of the Royal College of Surgeons of England·2026
Same author

Molecular profile and clinical impact of MDM2 amplification in patients with advanced biliary tract cancer.

ESMO open·2025
Same author

Impact of carbapenem-targeted antimicrobial stewardship interventions: an interrupted time-series analysis.

The Journal of hospital infection·2023
Same author

Collagen adhesin protein and necrotic enteritis B-like toxin as biomarkers for early diagnosis of necrotic enteritis in commercial broiler chickens.

Poultry science·2023
Same author

Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.

AJNR. American journal of neuroradiology·2020
Same author

Off-line learning in a rhythmic bimanual task: early feedback dependency is reduced over wakefulness.

Psychological research·2020

The tumor suppressor protein p53 directly reduces BRCA1 expression, impacting DNA damage response. This discovery reveals a new p53/BRCA1 pathway crucial for cellular stress responses.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Mutations in BRCA1 and p53 tumor suppressor genes are linked to increased cancer risk.
  • Both genes play critical roles in DNA damage response pathways.

Purpose of the Study:

  • To investigate a potential functional connection between the p53 and BRCA1 genes.
  • To elucidate the regulatory relationship between p53 activity and BRCA1 expression.

Main Methods:

  • Analysis of BRCA1 expression levels following p53 induction.
  • Utilizing nuclear run-on assays to assess transcriptional regulation.
  • Employing luciferase reporter assays to confirm p53-mediated repression of BRCA1.

Main Results:

Related Experiment Videos

  • BRCA1 expression is significantly down-regulated upon p53 induction during growth arrest, senescence, or apoptosis.
  • DNA-damaging agents induce p53-dependent negative regulation of BRCA1 prior to cell cycle arrest.
  • Data indicate transcriptional repression as the primary mechanism for altered BRCA1 expression.

    • Conclusions:

    • BRCA1 expression is actively controlled by the presence and activity of wild-type p53.
    • A novel intracellular p53/BRCA1 pathway is suggested to mediate cellular responses to stress conditions.
    • This pathway provides new insights into cancer predisposition and DNA repair mechanisms.